The new direction of nuclear medicine
Publish place: Iranian Journal of Nuclear Medicine، Vol: 4، Issue: 1
Publish Year: 1375
نوع سند: مقاله ژورنالی
زبان: English
View: 120
This Paper With 7 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_IRJNM-4-1_001
تاریخ نمایه سازی: 7 تیر 1401
Abstract:
The role of the nuclear medicine has changed, from the early days when it was the only alternative to x-rays, to the present, when nuclear images are interpreted in light of specific metabolic processes, not anatomy. The development of specific receptor targeting radiopharmaceuticals, markers of viability using PETor SPECT, analogues of neurotransmitters etc., have placed the nuclear medicine physician into the realm of an in vivo biochemist or pharmacologist, or an applied physiologist. The current role of nuclear imaging is not merely to detect an abnormality, but to characterize the pathophysiology, risk stratify, direct therapy, and offer prognosis. As we recognize that the information obtained from a scintigram is occurring below the cellular level, we are entering the age of "Molecular Nuclear Medicine".
Authors
David Greyson
Department of Medical Imaging, St. Michael&#۰۳۹;s Hospital, University of Toronto, Ontario, Canada